Every material Form 8-K Stryker has filed with the SEC since December 04, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Stryker Corporation announced its third quarter 2026 operating results, reporting a 7.7% increase in net sales to $6.5 billion alongside a decline in reported net earnings. The company updated its full year 2026 guidance, now expecting organic net sales growth in the range of 6.5% to 7.0%. Additionally, the Board of Directors approved a $3.0 billion increase to the share repurchase program following $1.0 billion in repurchases during the quarter.
Reported net sales increased 7.7% to $6.5 billion for the third quarter of 2026.
Reported net earnings decreased 12.3% to $753 million, or $1.96 per diluted share, while adjusted diluted EPS increased 10.3% to $3.52.
Full year 2026 organic net sales growth is now expected to be in the range of 6.5% to 7.0%.
Stryker repurchased $1.0 billion of its common stock in the third quarter of 2026 and expanded its share repurchase program by $3.0 billion in October 2026.
Stryker said CEO Kevin Lobo will step down on December 31, 2026, and become Executive Chair of the Board on January 1, 2027. President and COO Spencer Stiles will become CEO on the same date and join the Board, which the company is expanding from 10 to 11 members. The filing describes this as a planned succession process and does not report any change to financial results or guidance.
Kevin Lobo resigns as CEO on December 31, 2026, and becomes Executive Chair effective January 1, 2027
Spencer Stiles, President and COO since January 2026, becomes CEO and a Board member effective January 1, 2027
Stiles's base salary rises to $1,320,000 and his annual bonus target to 150% of salary; a February 2027 equity award with a target grant value of $14,200,000 will be recommended to independent directors
Lobo's base salary, bonus target and benefit eligibility are unchanged, but he will not receive new stock awards as Executive Chair
Stryker reported second quarter 2026 net sales of $6.6 billion, up 9.4% from a year earlier, with reported diluted EPS of $3.30 and adjusted diluted EPS of $3.69. The company narrowed its full year 2026 guidance to organic net sales growth of 8.3% to 9.3% and adjusted diluted EPS of $14.95 to $15.10, and its CEO said the company is recovering from the cyber incident first reported on March 11, 2026.
Net sales $6.6 billion, up 9.4% (organic up 9.0%); MedSurg and Neurotechnology $3.6 billion, Orthopaedics $3.0 billion
Reported diluted EPS $3.30, up 44.1%; adjusted diluted EPS $3.69, up 17.9%
2026 guidance narrowed: organic net sales growth 8.3% to 9.3%; adjusted diluted EPS $14.95 to $15.10
Stryker filed an 8-K to recast its consolidated financial statements for the three years ended December 31, 2025, to reflect a reorganization that created the Ortho Tech business. The company states that the recast is not a restatement and does not amend its audited financial statements. The company will continue to report two segments, MedSurg and Neurotechnology, and Orthopaedics.
Ortho Tech combines orthopaedic instruments from the Instruments business with Mako and enabling technologies from Other Orthopaedics.
Ortho Tech 2025 net sales were $2,770 million, up 11.8% as reported.
The filing covers 2023, 2024 and 2025, with the recast presented in Exhibit 99.1.
The filing does not update MD&A; more current information is in the Form 10-Q for the quarter ended March 31, 2026.
Stryker said its Chief Accounting Officer, William E. Berry, Jr., will retire effective September 1, 2026, and Vice President and Corporate Controller Emily Baculik will take over the role on the same date. Mr. Berry will then serve as Advisor to the Chief Financial Officer until August 15, 2027, under a transition agreement, which is routine succession for shareholders.
William E. Berry, Jr. retires as Vice President, Chief Accounting Officer effective September 1, 2026
Emily Baculik, Vice President, Corporate Controller since November 2024, becomes chief accounting officer effective September 1, 2026
Ms. Baculik's annualized base salary rises to $420,000 and her bonus target is 45% of base salary
Mr. Berry's advisory period runs until August 15, 2027, with base salary of $510,000 and no new equity awards
Stryker reported first quarter 2026 results on April 30, 2026, with net sales up 2.6% to $6.0 billion. Adjusted earnings per diluted share fell 8.5% to $2.60, while reported diluted EPS rose 14.2% to $1.93, and the company maintained its full-year 2026 guidance. The company cited its recovery from a cyber incident first reported on March 11, 2026.
Net sales rose 2.6% to $6.0 billion; organic net sales rose 2.4%.
Adjusted diluted EPS fell 8.5% to $2.60; reported diluted EPS rose 14.2% to $1.93.
Adjusted operating income margin contracted 180 bps to 21.1%.
Full-year 2026 guidance maintained: organic sales growth of 8.0% to 9.5% and adjusted EPS of $14.90 to $15.10.
Stryker said in a further update to its March 11 and March 12 disclosures that its cybersecurity incident is contained, and that no malicious activity directed at customers, suppliers, vendors or partners has been identified. The company said the incident disrupted its corporate network, and it has not yet determined whether the incident is reasonably likely to have a material impact on the company, so the operational and financial effects remain under assessment.
Earlier 8-K filings on March 11 and March 12, 2026 first disclosed the incident; this update is dated March 23, 2026.
Palo Alto Networks Unit 42 letter dated March 20, 2026 reports no evidence of unauthorized activity since March 11, 2026 and no active persistent access.
Disruption affected the corporate network, including the Microsoft environment; the company says manufacturing capability is ramping as critical lines and plants come back online.
The company has not yet determined whether the incident is reasonably likely to have a material impact on the company.
Stryker disclosed in an update to customers that a cybersecurity incident, which caused a global disruption to its Microsoft environment, is ongoing and continues to disrupt order processing, manufacturing and shipping. The company says patient-related services and connected products do not appear to be affected, but the full scope and financial impact are not yet known.
Operations remain disrupted, including order processing, manufacturing and shipping, per a March 12, 2026 update by CISO Dave Nathans
Company does not believe patient-related services were disrupted or connected products were impacted
Investigation is ongoing; operational and financial impacts are not yet known and no dollar estimate was given
Stryker said on March 11, 2026 it identified a cybersecurity incident that has caused a global disruption to its Microsoft environment and limited access to some information systems and business applications. The company says it has no indication of ransomware or malware, believes the incident is contained, and is working to restore affected functions, but the restoration timeline and the full financial impact are not yet known.
Incident identified March 11, 2026; company activated its cybersecurity response plan and engaged external advisors and cybersecurity experts
Disruptions and limited system access are expected to continue; no restoration timeline has been set
Company has not yet determined whether the incident is reasonably likely to have a material impact
Stryker reported fourth-quarter 2025 net sales of $7.2 billion, up 11.4%, with reported diluted EPS of $2.20, up 56.0%, and adjusted EPS of $4.47, up 11.5%. For full-year 2025, net sales reached $25.1 billion and adjusted EPS was $13.63, and the company expects 2026 adjusted EPS of $14.90 to $15.10 and organic sales growth of 8.0% to 9.5%.
Q4 2025 reported net sales $7.2 billion, up 11.4%; organic growth 11.0%
Q4 reported diluted EPS $2.20 (up 56.0%), boosted by a $589 million tax benefit; adjusted EPS $4.47 (up 11.5%)
Stryker said Spencer Stiles, currently Group President of Orthopaedics, will become President and Chief Operating Officer effective January 1, 2026, with responsibility for the company's global businesses, strategy and mergers and acquisitions. Dylan Crotty, now President of Instruments, will succeed Stiles as Group President, Orthopaedics on the same date.
Stiles becomes President and COO effective January 1, 2026, and will lead global businesses, strategy and M&A
Stiles's annualized base salary rises to $1,000,000 with a bonus target of 100% of base salary
Crotty becomes Group President, Orthopaedics effective January 1, 2026, with base salary rising to $700,000 and a bonus target of 85%
Board committee recommendation for February 2026 long-term incentive awards: about $6,000,000 for Stiles and about $3,000,000 for Crotty
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Stryker filing is on SEC EDGAR ↗. 8-K briefs of other companies →